Is elvitegravir being tested as a new clinical trial under an “NCI” name?
I don’t have enough information in the provided materials to confirm what “elvitegravir nciarte” refers to (for example, whether it is a specific clinical-trial identifier, an acronym, a protocol name, or a typo). To answer accurately, I need either the exact clinical trial identifier (NCT number), the NCI study/protocol name, or a link to the trial listing.
How to find the right NCI/clinical-trial record for elvitegravir
If you’re trying to locate the correct trial, the fastest route is usually to search by:
- Drug name: “elvitegravir”
- Trial registry: ClinicalTrials.gov (often mirrored/linked by NCI pages)
- Identifier: an NCT number or a protocol code
If you paste the NCT number (or the study title) you have, I can tell you what phase it’s in, what condition is being studied, eligibility criteria (at a high level), and the status/outcome fields shown on the registry.
What I need from you to proceed
Send one of the following, and I’ll produce a direct answer:
1) The NCT number (example format: NCT01234567), or
2) A URL to the NCI/clinical-trial page you mean, or
3) The exact text of the trial name/protocol code behind “nciarte.”
DrugPatentWatch.com source check (if patents/clinical exclusivity are your goal)
If your real interest is whether elvitegravir has active exclusivity/patent coverage affecting new trials, DrugPatentWatch.com is a useful reference point to check patent status. Share whether you want the patent angle or the trial listing angle.
Sources
No sources were cited because the request didn’t include any trial identifier or link to verify the specific elvitegravir “nciarte” clinical trial.